Catalogue of CDE drug review consultation in March 2016
-
Last Update: 2016-04-11
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
From March 16 to March 18, 2016, the drug review center organized the second drug review consultation meeting in 2016 in Jiangxi Hotel, Beijing A total of 160 experts were invited to attend the meeting At the same time, 22 applicants for registration sent 112 representatives to attend the meeting The technical reviewers of the drug Audit Center have fully discussed and exchanged relevant technical issues with experts and representatives of the sponsor Attachment: Catalogue of drug review and consultation meeting in March 2016 No variety name 1 Banlangen Granules (children type) 2 Genistein and genistein tablets 3 Xigliptin metformin tablets (I) and (II) 4 Xigliptin phosphate tablets 5 clomiphene citrate tablet 6 rifepime cigarette tablet (Ⅲ) 7 ethylamine pyrazine rifepime cigarette tablet (III) 8 pseudoginsenoside GQ injection 9 antibacterial peptide PL-5, antimicrobial peptide PL-5 spray 10 12 Ganduqing granules of pica hepatitis B vaccine (CHO cells) for injection of rat nerve growth factor 11 13 Ginseng Polysacchride Injection 14 Shan Jin Lian soft capsule 15 three ginseng spray Pegylated recombinant Candida uricaoxidase17 and magnolol for injection, and freeze-dried powder for injection and magnolol liposomes 18 Baxuan tablet
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
